Analysts at Barclays Maintained their Past ‘Equal-Weight’ rating on Shares Dentsply Sirona (NASDAQ:XRAY), Set a $41 Price Objective

August 9, 2018 - By Vernon Prom


Investors sentiment increased to 0.5 in 2018 Q1. Its up 0.30, from 0.2 in 2017Q4. It increased, as 1 investors sold DENTSPLY SIRONA Inc. shares while 3 reduced holdings. 0 funds opened positions while 2 raised stakes. 569,543 shares or 38.02% more from 412,640 shares in 2017Q4 were reported.

Cibc Ww Mkts Corp, New York-based fund reported 242,573 shares. The New York-based Tirschwell Loewy has invested 1.74% in DENTSPLY SIRONA Inc. (NASDAQ:XRAY). Gemmer Asset Mgmt Lc stated it has 241 shares. West Oak Cap Ltd Liability Com accumulated 6,290 shares. Cardinal Management holds 1.1% or 69,521 shares in its portfolio.

Since May 9, 2018, it had 2 insider buys, and 3 insider sales for $2.89 million activity. On Wednesday, May 9 the insider ALEXOS NICHOLAS W bought $2.24M. $19,316 worth of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) was sold by COLEMAN MICHAEL J. $1.00M worth of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) was bought by Casey Donald M Jr..

Dentsply Sirona (NASDAQ:XRAY) Rating Reaffirmed

In analysts report issued this morning, Barclays restate their Equal-Weight rating on Dentsply Sirona (NASDAQ:XRAY) shares. The target price per share means a possible upside of 1.01 % from firm’s last stock price.


Among 11 analysts covering Dentsply Sirona (NASDAQ:XRAY), 4 have Buy rating, 0 Sell and 7 Hold. Therefore 36% are positive. Dentsply Sirona has $70 highest and $38 lowest target. $53’s average target is 30.57% above currents $40.59 stock price. Dentsply Sirona had 20 analyst reports since March 2, 2018 according to SRatingsIntel. As per Tuesday, June 5, the company rating was downgraded by Northcoast. The stock of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has “Equal-Weight” rating given on Wednesday, August 8 by Stephens. The firm has “Equal-Weight” rating by Morgan Stanley given on Wednesday, August 8. As per Wednesday, August 8, the company rating was maintained by Jefferies. The firm has “Neutral” rating by Robert W. Baird given on Tuesday, August 7. The firm earned “Overweight” rating on Monday, March 5 by JP Morgan. H.C. Wainwright maintained the stock with “Hold” rating in Tuesday, May 8 report. The rating was maintained by H.C. Wainwright on Tuesday, March 27 with “Hold”. Morgan Stanley maintained the shares of XRAY in report on Thursday, June 14 with “Overweight” rating. On Tuesday, May 8 the stock rating was maintained by Stifel Nicolaus with “Buy”.

The stock increased 0.51% or $0.21 during the last trading session, reaching $40.59. About 932,994 shares traded. DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has declined 26.16% since August 9, 2017 and is downtrending. It has underperformed by 38.73% the S&P500.

DENTSPLY SIRONA Inc. designs, develops, makes, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company has market cap of $9.03 billion. It operates through two divisions, Dental and Healthcare Consumables; and Technologies. It currently has negative earnings. The firm provides dental consumable products, including endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprising dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

More notable recent DENTSPLY SIRONA Inc. (NASDAQ:XRAY) news were published by: which released: “Dentsply Sirona Reports Second Quarter 2018 Results” on August 07, 2018, also with their article: “The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos’ Maiden Earnings, Paratek Awaits Adcom Verdict” published on August 08, 2018, published: “10 Biggest Price Target Changes For Wednesday” on August 08, 2018. More interesting news about DENTSPLY SIRONA Inc. (NASDAQ:XRAY) were released by: and their article: “77 Biggest Movers From Yesterday” published on August 08, 2018 as well as‘s news article titled: “Premarket analyst action – healthcare” with publication date: August 07, 2018.


Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.